Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-glaucoma Agent

Natural or synthetic Anti-glaucoma Agents relieve or prevent glaucoma, a condition characterized by increased intraocular pressure, excavation, and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract Long‐term treatment of glaucoma, a major leading cause of blindness, is challenging due to poor patient compliance… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
2014
2014
Nipradilol (Nip) is registered as an anti-glaucoma agent. More recently, a protective effect of Nip has been demonstrated in… Expand
2014
2014
Glaucoma is the second leading cause of blindness in the US. Brimonidine tartrate (BT) is a modern anti-glaucoma agent that is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
To evaluate the pharmacological properties of cilostazol (CLZ), we examined its intraocular pressure (IOP) -lowering effect. CLZ… Expand
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 6
Highly Cited
2004
Highly Cited
2004
Prostaglandin (PG) D(2) ethanolamide (prostamide D(2)) was reduced to 9alpha,11beta-PGF(2) ethanolamide (9alpha,11beta-prostamide… Expand
2004
2004
  • K. Buxey
  • Clinical & experimental optometry
  • 2004
  • Corpus ID: 21521326
Background: Diffuse lamellar keratitis (DLK) is a relatively uncommon complication of the refractive procedure, laser‐assisted in… Expand
Highly Cited
2000
Highly Cited
2000
Timolol was the first beta blocker to be used as an anti-glaucoma agent and to date remains as the standard because none of the… Expand
1993
1993
We administered UF-021 isopropyl unoprostone (Rescula) ophthalmic solution, a new prostaglandin-related compound developed as an… Expand
1992
1992
The ophthalmic solution of UF-021, a novel prostaglandin (PG) related compound, was investigated for its intraocular pressure… Expand